Global Clinical Biomarker Testing Market
As the global economy mends, the 2021 growth of Clinical Biomarker Testing will have significant ... Read More
As the global economy mends, the 2021 growth of Cell and Gene Therapy Tools and Reagents will have significant change from previous year. According to our (LP Information) latest study, the global Cell and Gene Therapy Tools and Reagents market size is USD million in 2022 from USD 6954.4 million in 2021, with a change of % between 2021 and 2022. The global Cell and Gene Therapy Tools and Reagents market size will reach USD 11700 million in 2028, growing at a CAGR of 7.7% over the analysis period.
The United States Cell and Gene Therapy Tools and Reagents market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cell and Gene Therapy Tools and Reagents market, reaching US$ million by the year 2028. As for the Europe Cell and Gene Therapy Tools and Reagents landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cell and Gene Therapy Tools and Reagents players cover ATHERSYS INC., AVROBIO, BIO-RAD LABORATORIES, and BIO-TECHNE, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Tools and Reagents market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Chemiluminescent Immunoassays (CLIA)
Fluoroimmunoassay
Multiplex Assays
Rapid Diagnostic Technologies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Laboratories
Phamacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
ATHERSYS INC.
AVROBIO
BIO-RAD LABORATORIES
BIO-TECHNE
CELLGENIX
MESOBLAST LTD.
ORGANICELL
QUANTERIX
STEMCELL TECHNOLOGIES
THERMO FISHER
LUMINEX CORP.
As the global economy mends, the 2021 growth of Clinical Biomarker Testing will have significant ... Read More
As the global economy mends, the 2021 growth of Topical Absorbable Hemostat will have significant ... Read More
As the global economy mends, the 2021 growth of Next-Generation Multi-purpose Biosensors will hav ... Read More
As the global economy mends, the 2021 growth of WiFi Enabled LTE Small Cell Gateway will have sig ... Read More